While this necessitates further exploration into the functional roles of these molecules within the tumor development, the correlation of BRAFV600E-mutated PTC cases with methylated p16 and elevated ETS1 expression highlights a subtype of PTC that may benefit from more targeted therapeutic strategies. Here, ETS1 is linked to neoplasm.